A phase II study of gemcitabine in pancreatic endocrine tumor
Phase 2
- Conditions
- pancreatic endocrine tumor
- Registration Number
- JPRN-UMIN000001487
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1) Intestinal pneumonia or lung fibrosis 2) Massive pleural or abdominal effusion 3) Symptomatic brain metastasis 4) History of other active malignancy 5) Severe infection 6) Severe complication 7) Pregnancy or the desire to preserve fecundity 8) uncontrollable endocrine symptom 9) Inadequate physical condition, as diagnosed by primary physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate
- Secondary Outcome Measures
Name Time Method